X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (911) 911
Newspaper Article (69) 69
Publication (62) 62
Newsletter (44) 44
Conference Proceeding (41) 41
Book Review (9) 9
Book Chapter (4) 4
Magazine Article (3) 3
Book / eBook (1) 1
Government Document (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (563) 563
thymosin - therapeutic use (424) 424
animals (360) 360
index medicus (300) 300
thymosin (289) 289
male (284) 284
thymosin - analogs & derivatives (268) 268
female (231) 231
mice (187) 187
adult (147) 147
middle aged (143) 143
thymosin - pharmacology (139) 139
adjuvants, immunologic - therapeutic use (101) 101
aged (93) 93
thymosin - metabolism (90) 90
biological products industry (85) 85
thymosin β4 (78) 78
rats (74) 74
antiviral agents - therapeutic use (73) 73
drug therapy, combination (67) 67
research (67) 67
thymalfasin (67) 67
immunotherapy (65) 65
peptides (65) 65
thymosin - genetics (65) 65
apoptosis (64) 64
cancer (64) 64
clinical trials (62) 62
thymus hormones - therapeutic use (62) 62
treatment outcome (62) 62
t-lymphocytes - immunology (61) 61
thymosin - administration & dosage (59) 59
oncology (58) 58
inflammation (57) 57
proteins (57) 57
angiogenesis (55) 55
pharmacology & pharmacy (55) 55
wound healing (55) 55
expression (53) 53
multidisciplinary sciences (53) 53
hepatitis b, chronic - drug therapy (52) 52
medicine, research & experimental (52) 52
analysis (51) 51
disease models, animal (48) 48
health aspects (48) 48
thymosin beta 4 (48) 48
cell biology (46) 46
pharmaceutical industry (45) 45
interferon-alpha - therapeutic use (44) 44
cells (43) 43
biotechnology & applied microbiology (41) 41
cells, cultured (41) 41
immunology (41) 41
research article (41) 41
mice, inbred c57bl (40) 40
thymosin beta-4 (40) 40
intellectual property (39) 39
thymosin α1 (39) 39
medicine (38) 38
patents (38) 38
stem cells (38) 38
thymosin alpha-1 (38) 38
adolescent (37) 37
clinical trials as topic (37) 37
gene expression (37) 37
biochemistry & molecular biology (36) 36
care and treatment (36) 36
therapy (36) 36
time factors (36) 36
in-vitro (35) 35
interferon (35) 35
gastroenterology & hepatology (34) 34
neoplasms - drug therapy (34) 34
rodents (34) 34
article (33) 33
thymosin - chemistry (33) 33
actin (32) 32
combination therapy (32) 32
cytokines (32) 32
thymosin - physiology (32) 32
amino acid sequence (31) 31
heart (31) 31
thymosin alpha 1 (31) 31
child (30) 30
heart attacks (30) 30
regeneration (30) 30
biology (29) 29
immunologic deficiency syndromes - drug therapy (29) 29
biological products (28) 28
cell proliferation (28) 28
thymosin - adverse effects (28) 28
wound healing - drug effects (28) 28
medical research (27) 27
science (27) 27
studies (27) 27
combined modality therapy (26) 26
neoplasms - therapy (26) 26
fibrosis (25) 25
neurosciences (25) 25
thymic hormones (25) 25
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (957) 957
Chinese (36) 36
Russian (20) 20
German (7) 7
Japanese (6) 6
Polish (5) 5
French (3) 3
Italian (3) 3
Bulgarian (2) 2
Czech (1) 1
Hungarian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
BioMed research international, ISSN 2314-6133, 2018, Volume 2018, pp. 3421568 - 8
Thymosin 4 (T 4) treatment was known to show the potential therapeutic effects on diabetic complications. This study was performed to determine if T 4... 
Diabetes Mellitus, Experimental - blood | Animals | Streptozocin | Injections, Intraperitoneal | Thymosin - metabolism | Mice | Thymosin - therapeutic use
Journal Article
Journal of Trauma and Acute Care Surgery, ISSN 2163-0755, 02/2016, Volume 80, Issue 2, pp. 335 - 340
Ulinastatin (UTI) and thymosin α1 (Tα1) have been investigated for their immunoregulatory properties in patients with severe sepsis. However, it is unclear... 
meta-analysis | thymosin α1 | systematic review | severe sepsis | Ulinastatin | Sepsis - drug therapy | Trypsin Inhibitors - therapeutic use | Glycoproteins - therapeutic use | Humans | Thymosin - analogs & derivatives | Drug Therapy, Combination | Thymosin - therapeutic use | Adjuvants, Immunologic - therapeutic use | Sepsis - mortality
Journal Article
Journal Article
Journal Article
International Immunopharmacology, ISSN 1567-5769, 12/2015, Volume 29, Issue 2, pp. 377 - 382
This meta-analysis was performed to evaluate the efficacy of ulinastatin (UTI) and thymosin α1 (Tα1) based immunomodulatory strategy in sepsis patients. A... 
Sepsis | Thymosin α1 | Ulinastatin | Meta-analysis | Sepsis - drug therapy | Glycoproteins - therapeutic use | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Thymosin - analogs & derivatives | Thymosin - therapeutic use | Immunologic Factors - therapeutic use
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 10/2012, Volume 1270, Issue 1, pp. 8 - 12
Journal Article
Expert Review of Anti-infective Therapy, ISSN 1478-7210, 11/2011, Volume 9, Issue 11, pp. 1013 - 1033
Currently the treatment mainstay of sepsis is early and appropriate antibiotic therapy, accompanied by aggressive fluid administration, the use of vasopressors... 
immunomodulation | septic shock | inflammation | immunomodulatory strategies | apoptosis | immunoparalysis | sepsis | endotoxin | ACTIVATED RECEPTOR-GAMMA | ACUTE LUNG INJURY | ACUTE-RENAL-FAILURE | RANDOMIZED CONTROLLED-TRIAL | CHEMICALLY-MODIFIED TETRACYCLINE | HUMAN SOLUBLE THROMBOMODULIN | BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN | TUMOR-NECROSIS-FACTOR | PHARMACOLOGY & PHARMACY | SYSTEMIC INFLAMMATORY RESPONSE | PLACEBO-CONTROLLED TRIAL | Humans | Hydrocortisone - therapeutic use | Sepsis - complications | Anti-Bacterial Agents - therapeutic use | Bacterial Infections - complications | Hydrocortisone - administration & dosage | Inflammation - complications | Sepsis - drug therapy | Bacterial Infections - immunology | Inflammation - drug therapy | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Multiple Organ Failure - complications | Gram-Negative Bacteria - physiology | Antibodies - therapeutic use | Sepsis - immunology | Immunity, Innate - drug effects | Bacterial Infections - drug therapy | Immunomodulation | Immunologic Factors - administration & dosage | Clinical Trials as Topic | Inflammation - immunology | Antibodies - administration & dosage | Gram-Negative Bacteria - drug effects | Adaptive Immunity - drug effects | Animals | Multiple Organ Failure - immunology | Protein C - administration & dosage | Mice | Anti-Bacterial Agents - administration & dosage | Multiple Organ Failure - drug therapy | Protein C - therapeutic use | Immunologic Factors - therapeutic use | Infection | Corticosteroids | Cytokines | Immunotherapy | Clinical trials | Septic shock | Inflammation | DNA binding proteins | Health aspects | Statins | Apoptosis | Transcription factors | Immune response | Mortality | Coagulation | Homeostasis | Hydrocortisone | Reviews | Antibiotics | statins | Sepsis | activated protein C
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2013, Volume 4, Issue 4, p. CD009004